82.63
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GEHC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$78.78
Aprire:
$79.71
Volume 24 ore:
6.99M
Relative Volume:
2.00
Capitalizzazione di mercato:
$37.64B
Reddito:
$20.25B
Utile/perdita netta:
$2.29B
Rapporto P/E:
17.08
EPS:
4.8366
Flusso di cassa netto:
$1.40B
1 W Prestazione:
+4.25%
1M Prestazione:
-0.23%
6M Prestazione:
+16.97%
1 anno Prestazione:
-4.95%
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Nome
Ge Healthcare Technologies Inc
Settore
Industria
Telefono
833-735-1139
Indirizzo
500 WEST MONROE STREET, CHICAGO
Confronta GEHC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
GEHC
Ge Healthcare Technologies Inc
|
82.63 | 35.89B | 20.25B | 2.29B | 1.40B | 4.8366 |
|
ABT
Abbott Laboratories
|
108.20 | 189.57B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
360.66 | 137.99B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
101.84 | 132.28B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
75.50 | 135.87B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
EW
Edwards Lifesciences Corp
|
79.77 | 47.64B | 5.88B | 1.34B | 799.60M | 2.3489 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-15 | Downgrade | UBS | Neutral → Sell |
| 2025-10-13 | Iniziato | Barclays | Equal Weight |
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-05 | Aggiornamento | UBS | Sell → Neutral |
| 2025-03-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-26 | Downgrade | UBS | Neutral → Sell |
| 2024-09-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-09-09 | Iniziato | JP Morgan | Neutral |
| 2024-08-06 | Iniziato | Stifel | Buy |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-02-15 | Iniziato | HSBC Securities | Buy |
| 2024-02-12 | Aggiornamento | UBS | Sell → Neutral |
| 2023-11-30 | Iniziato | Jefferies | Hold |
| 2023-11-27 | Downgrade | UBS | Neutral → Sell |
| 2023-09-19 | Iniziato | Citigroup | Buy |
| 2023-08-25 | Iniziato | Argus | Buy |
| 2023-08-16 | Iniziato | Wells Fargo | Overweight |
| 2023-07-31 | Iniziato | BofA Securities | Neutral |
| 2023-06-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Iniziato | Oppenheimer | Outperform |
| 2023-04-26 | Iniziato | UBS | Neutral |
| 2023-04-19 | Iniziato | Piper Sandler | Overweight |
| 2023-04-10 | Iniziato | BTIG Research | Neutral |
| 2023-03-13 | Iniziato | Evercore ISI | Outperform |
| 2023-02-17 | Iniziato | Mizuho | Buy |
| 2023-01-19 | Iniziato | Redburn | Buy |
Mostra tutto
Ge Healthcare Technologies Inc Borsa (GEHC) Ultime notizie
GE HealthCare: Q4 Earnings Snapshot - theheraldreview.com
GE HealthCare Earnings Call: Growth Amid Tariff Strain - TipRanks
Does GE HealthCare’s 2025 Beat And AI Push Reshape The Bull Case For GEHC? - Yahoo Finance
GE HealthCare Stock Rises. Earnings Were a Relief. - Barron's
GE HealthCare Technologies Q4 2025 Earnings Highlights - Intellectia AI
BTIG Research Adjusts GE Healthcare Technologies PT to $91 From $87, Maintains Buy Rating - marketscreener.com
GE HealthCare stock price target raised to $91 from $87 at BTIG - Investing.com
GE HealthCare Beats Earnings But Margin Pressure, Tariff Costs Could Weigh On Profitability - Benzinga
Tranche Update on GE HealthCare Technologies Inc.'s Equity Buyback Plan announced on April 30, 2025. - marketscreener.com
GE HealthCare Technologies Stock Climbs 5% Over Revenue Growth In Q4 - Nasdaq
GE HealthCare Q4 2025 slides: organic growth persists despite tariff headwinds - Investing.com India
GE HealthCare (GEHC) Q4 2025 Earnings Transcript - The Globe and Mail
GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls - Zacks Investment Research
Earnings call transcript: GE HealthCare’s Q4 2025 reveals steady growth By Investing.com - Investing.com India
Earnings call transcript: GE HealthCare’s Q4 2025 reveals steady growth - Investing.com
Compared to Estimates, GE HealthCare (GEHC) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
GE HealthCare's (NASDAQ:GEHC) Q4 CY2025: Beats On Revenue - Finviz
GE HealthCare rises after Q4 beat, outlook (GEHC:NASDAQ) - Seeking Alpha
GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices - Yahoo Finance
Human-Impact Story Reinforces GE HealthCare Oncology Focus - TipRanks
GE HealthCare Techs Q4 Earnings Summary & Key Takeaways - Benzinga
GE HealthCare Technologies (GEHC) Valuation Check As Earnings Near And Allia Moveo Launch Gains Attention - Yahoo Finance
GE HealthCare Techs: Q4 Earnings Insights - Benzinga
GE HealthCare Technologies Inc. (GEHC) Stock: Q4 Revenue Climbs 7% as Diagnostics and Imaging Lead 2025 Growth - CoinCentral
GE HealthCare Stock Rises. Why Earnings Were a Relief. - Barron's
GE Healthcare Q4 Adjusted Earnings Fall, Revenue Rises; 2026 Outlook Set -- Shares Up Pre-Bell - marketscreener.com
GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue - The Wall Street Journal
GE HealthCare Techs Earnings Report: Q4 Overview - Benzinga
GE HealthCare’s (NASDAQ:GEHC) Q4 CY2025: Beats On Revenue - Yahoo Finance
GE HealthCare Technologies Inc. SEC 10-K Report - TradingView
GE HealthCare Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
GE HEALTHCARE TECHNOLOGIES ($GEHC) Releases Q4 2025 Earnings - Quiver Quantitative
Form 10-K GE HealthCare Technologi For: Dec 31 - StreetInsider
GE HealthCare Technologies Inc. Reveals Retreat In Q4 Profit - Nasdaq
(GEHC) GE Healthcare Technologies Expects Full Year 2026 Adjusted EPS Range $4.95$5.15, vs. FactSet Est of $4.94 - marketscreener.com
GE HealthCare's Q4 revenue up 7.1% to $5.7 billion - breakingthenews.net
GE HealthCare: Fourth Quarter Earnings Overview - bitget.com
Commit To Purchase GE HealthCare Technologies At $50, Earn 4% Using Options - Nasdaq
GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy? - Nasdaq
Exploring GE HealthCare Techs's Earnings Expectations - Benzinga
GE HealthCare Q4 2025 Earnings Report: Projections & AnalysisNews and Statistics - IndexBox
GE HealthCare (GEHC) Q4 Earnings Report Preview: What To Look For - Finviz
GE HealthCare Receives FDA Clearance for Allia Moveo Interventional Imaging System - HIT Consultant
GE Healthcare's Allia Moveo Platform Receives FDA Clearance, CE Mark - Diagnostic and Interventional Cardiology
Whale Trades: Is GE HealthCare Technologies Inc in accumulation or distribution phaseJuly 2025 Weekly Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
FDA Grants 510(k) Clearance to GE HealthCare’s Allia Moveo - Medical Product Outsourcing
GE Healthcare Technologies' Imaging Platform Gets 510(k) Clearance, CE Marking - marketscreener.com
GE HealthCare wins FDA, CE mark approval for Allia Moveo image-guided platform - MassDevice
GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unpacking the 16.69% Potential Upside - DirectorsTalk Interviews
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Ge Healthcare Technologies Inc Azioni (GEHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):